Onderneming CMG Pharmaceutical Co Ltd Korea S.E.
Aandelen
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- | - |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Restriction
98,8
%
| - | - | 92 743 | 98,8 % | - |
Other
1,2
%
| - | - | 1 164 | 1,2 % | - |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
98,2
%
| 81 756 | 99,5 % | 92 176 | 98,2 % | +12,75% |
Asia
1,8
%
| - | - | 1 646 | 1,8 % | - |
International (Other)
0,1
%
| 14 | 0,0 % | 85 | 0,1 % | +497,05% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ju-Hyung Lee
CEO | Chief Executive Officer | 62 | 06-11-15 |
Sang-Ki Kim
BRD | Director/Board Member | 62 | 27-04-15 |
In-Chul Jung
IRC | Investor Relations Contact | 53 | - |
Se-Won Lee
AUD | Comptroller/Controller/Auditor | 79 | 30-03-15 |
Hyo-Mook Cho
SAM | Sales & Marketing | 66 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ju-Hyung Lee
CEO | Chief Executive Officer | 62 | 06-11-15 |
Sang-Ki Kim
BRD | Director/Board Member | 62 | 27-04-15 |
Seung-Chul Han
BRD | Director/Board Member | 61 | - |
Yoon-Sang Park
BRD | Director/Board Member | 64 | - |
Jong-Hwa Park
BRD | Director/Board Member | 69 | - |
Jong-Hyun Park
BRD | Director/Board Member | 60 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 138 892 244 | 102 997 131 ( 74,16 %) | 0 | 74,16 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,91% | 41,97 mld. | |
+22,40% | 22,34 mld. | |
+18,48% | 15,25 mld. | |
+16,12% | 14 mld. | |
+45,12% | 12,06 mld. | |
-9,58% | 6,8 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+14,18% | 5,49 mld. |
- Beurs
- Aandelen
- Koers A058820
- Koers
- Onderneming CMG Pharmaceutical Co Ltd